Advanced company searchLink opens in new window

OPPILAN PHARMA LIMITED

Company number 09610773

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 May 2024 AP01 Appointment of John Nuss as a director on 17 April 2024
08 May 2024 TM01 Termination of appointment of Christopher W. Krueger as a director on 17 April 2024
07 Mar 2024 AA Total exemption full accounts made up to 31 May 2023
07 Jun 2023 CS01 Confirmation statement made on 27 May 2023 with no updates
03 Mar 2023 AA Total exemption full accounts made up to 31 May 2022
01 Jun 2022 AA Total exemption full accounts made up to 31 May 2021
27 May 2022 CS01 Confirmation statement made on 27 May 2022 with no updates
08 Jul 2021 TM01 Termination of appointment of Jason Hong as a director on 19 August 2020
21 Jun 2021 CS01 Confirmation statement made on 27 May 2021 with updates
11 May 2021 SH03 Purchase of own shares.
02 Apr 2021 SH06 Cancellation of shares. Statement of capital on 26 February 2021
  • USD 26,276.158
30 Mar 2021 RESOLUTIONS Resolutions
  • RES09 ‐ Resolution of authority to purchase a number of shares
30 Mar 2021 SH08 Change of share class name or designation
18 Mar 2021 TM01 Termination of appointment of Jigar Choksey as a director on 26 February 2021
18 Mar 2021 AP01 Appointment of Jigar Choksey as a director on 21 October 2020
17 Mar 2021 TM01 Termination of appointment of Somasundaram Subramaniam as a director on 26 February 2021
17 Mar 2021 TM01 Termination of appointment of Norman Selby as a director on 26 February 2021
21 Feb 2021 SH08 Change of share class name or designation
30 Nov 2020 AP04 Appointment of Taylor Wessing Secretaries Limited as a secretary on 1 September 2020
30 Nov 2020 AD01 Registered office address changed from St. Johns Innovation Centre Cowley Road Cambridge Cambridgeshire CB4 0WS to 5 New Street Square London EC4A 3TW on 30 November 2020
15 Oct 2020 AA Total exemption full accounts made up to 31 May 2020
24 Jul 2020 CS01 Confirmation statement made on 27 May 2020 with updates
24 Jul 2020 SH01 Statement of capital following an allotment of shares on 19 August 2019
  • USD 26,318.033
18 Mar 2020 AA Total exemption full accounts made up to 31 May 2019
06 Feb 2020 SH01 Statement of capital following an allotment of shares on 17 April 2019
  • USD 26,305.627